Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06448208

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Sponsor: Memorial Sloan Kettering Cancer Center

View on ClinicalTrials.gov

Summary

People with neuroendocrine cancer typically have imaging scans before and after treatment, including positron emission tomography (PET) scans. The scans are analyzed using a set of criteria that describes how the disease has responded to treatment. The purpose of this study is to establish new criteria for doctors to use when evaluating these PET scans. Researchers are testing whether these new criteria are useful for predicting whether a person's cancer gets better, gets worse, or stays the same. Researchers will also compare these new criteria to the current standard criteria for evaluating imaging scans.

Official title: Definition of PET REsponSe CrItEria for Neuroendocrine Tumors (PRESCIENT)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

11

Start Date

2024-06-03

Completion Date

2026-06

Last Updated

2026-03-09

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

positron emission tomography (PET) scans

Before and after treatment.

Locations (1)

Memorial Sloan Kettering Cancer Center

New York, New York, United States